Influenza vaccine quadrivalent (Nitto/Osaka)

四价流感疫苗

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza vaccine quadrivalent (Nitto/Osaka)
Drug Alias NameSeasonal influenza HA vaccine - Nitto/OsakaNSV-0001
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOsaka UniversityNitto Denko
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNitto Denko Corporation
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A